Rongzhe Liu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Machine Learning

Acute Myeloid Leukemia

Ejection Fraction

Chemotherapy Induced

Top Venues

Journal of medical economics

Future oncology (London, England)

PharmacoEconomics

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Vallerie McLaughlin, Adnan Alsumali, Rongzhe Liu, Rogier Klok, Eliana C Martinez, Iman Nourhussein, David Bernotas, Jestinah Chevure, Christine Pausch, Janethe De Oliveira Pena, Dominik Lautsch, Marius M Hoeper
Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH). Advances in therapy (2023)
Paul Cornes, John Kelton, Rongzhe Liu, Omer Zaidi, Jennifer M Stephens, Jingyan Yang
Real-world cost-effectiveness of primary prophylaxis with G-CSF biosimilars in patients at intermediate/high risk of febrile neutropenia. Future oncology (London, England) (2022)
Olalekan O Oluwole, Rongzhe Liu, Ibrahim Diakite, Chaoling Feng, Anik Patel, Iman Nourhussein, Julia Thornton Snider, Frederick L Locke
Cost-effectiveness of axicabtagene ciloleucel versus lisocabtagene maraleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the US. Journal of medical economics 25 (1) (2022)
Adnan Alsumali, Laurence M Djatche, Andrew H Briggs, Rongzhe Liu, Ibrahim Diakite, Dipen Patel, Yufei Wang, Dominik Lautsch
Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective. PharmacoEconomics 39 (11) (2021)
Rongzhe Liu, Olalekan O Oluwole, Ibrahim Diakite, Marc F Botteman, Julia Thornton Snider, Frederick L Locke
Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States. Journal of medical economics 24 (1) (2021)
Jingyan Yang, Rongzhe Liu, Anna Granghaud, Omer Zaidi, Jennifer M Stephens
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data. Journal of medical economics 24 (1) (2021)